Results 111 to 120 of about 14,135 (164)
[Strategies for immunotherapy-related hepatotoxicity in liver cancer]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2023 Zhi Y, Mao YM.
europepmc +1 more source
[Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC]. [PDF]
Zhongguo Fei Ai Za Zhi, 2023 Wang H, Han Y.
europepmc +1 more source
急性白血病患者化疗前后IL-2及IL-6水平的变化及临床意义
Zhongguo shiyan zhenduanxue, 2007 目的研究急性白血病患者化疗前后免疫功能的变化,探讨IL-2L-6的水平与患者预后的关系,并为临床治疗提供理论依据。方法应用放射免疫分析法对84例急性白血病患者进行化疗前后血清IL-2、IL-6含量检测,并与30例正常健康人作对照。结果急性白血病初治组及短期CR组IL-2水平分别为（18.76±9.43）ng/L,（29.48±6.39）ng/L明显低于长期CR组（46.73±8.26）ng/L及正常对照组（53.61±8.92）ng/L;初治组及短期CR组IL-6水平分别为（126.38±15.62 ...
李焱, 索晓慧, 牛志云
doaj
[Progress in Immunotherapy for Pulmonary Lymphoepithelioma Carcinoma]. [PDF]
Zhongguo Fei Ai Za ZhiSun W +5 more
europepmc +1 more source
[Emphasis on targeted and immunotherapy for liver injury in hepatocellular carcinoma]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2023 Nan YM, Liu LD, Zhao SX.
europepmc +1 more source
[Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanFu H, Shen L, Huang B, Ma S.
europepmc +1 more source
Linchuang shenzangbing zazhi, 2013 目的 观察阿魏酸哌嗪片治疗狼疮肾炎的临床疗效。方法 将80例狼疮肾炎患者随机分为两组。对照组给予激素加免疫抑制剂常规治疗。治疗组在对照组基础上加用阿魏酸哌嗪片治疗。观察并比较两组的临床疗效及血肌酐、尿素氮、血浆白蛋白、血红蛋白、尿蛋白定量、补体C3、抗核抗体、抗双链DNA抗体等指标的改变情况。结果 治疗组在治疗后血尿素氮、血肌酐、尿蛋白定量均明显下降,血浆白蛋白、血红蛋白较治疗前明显上升,且与对照组比较有统计学差异。结论 阿魏酸哌嗪联合激素加免疫抑制剂治疗狼疮肾炎疗效优于常规治疗,对狼疮肾炎患者纠正贫血、
doaj
[IGSF11: A Novel Target for Cancer Immunotherapy]. [PDF]
Zhongguo Fei Ai Za ZhiFeng Z +7 more
europepmc +1 more source
[Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2023 Wang T, Wang WT.
europepmc +1 more source
[Appropriate Duration of First-line Immunotherapy for Advanced NSCLC and Predictive Factors]. [PDF]
Zhongguo Fei Ai Za ZhiYin Y, Guo X, Ai J, Yue J, Deng L.
europepmc +1 more source